A randomized, single-dose, open-label, 4-sequence, 4-treatment crossover study assessing the pharmacokinetics of extended release carbidopa/levodopa versus commercially available formulations of carbidopa/levodopa.
Phase of Trial: Phase I
Latest Information Update: 30 Nov 2017
At a glance
- Drugs Levodopa/carbidopa (Primary) ; Levodopa/carbidopa/entacapone
- Indications Parkinson's disease
- Focus Pharmacokinetics
- 30 Nov 2017 New trial record